Skip to content

Author

D. Bedognetti

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

The impact of PROgnostic SIgnatures in stage II colon cancer patients enrolled in the phase III clinical trial TOSCA: the PROSIT study.

BACKGROUND Adjuvant chemotherapy (ACT) indication in stage II colorectal cancer (CRC) remains challenging, as clinical, pathological, and ctDNA inadequately predict benefit. Immune infiltration correlates with outcome, yet transcriptional signatures have not been systematically evaluated in prospective trial cohorts. W...

A. Puccini, Lorenzo Ferrando, G. Frige' et al. · 0 citations
Open access Nov 2026

A deep-learning model based on histological images predicts survival and pathological response to neoadjuvant chemotherapy and chemoimmunotherapy in breast cancer

An artificial intelligence (AI)-based deep-learning model enables accurate inference of a clinically validated immune gene-expression program directly from routine H&E slides and is independently associated with survival and pCR to NACT/NACTIT in eBC.

F. Bertucci, Gwenael Lumet, Mathieu Delattre et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.